PLK1 and pulmonary fibrosis: These results suggest that the increase in the mortality rate and weight loss by PLK1/2 inhibition in our experimental mouse model of lung fibrosis might have been due to alveolar injury and the inhibition of regeneration of lung epithelial cells.